The Patent Finder

Nanosystems L.L.C.

Also on record
Records under this name other than patents Nanosystems L.L.C. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Nanosystems L.L.C.

PatentTitleStatus Expires Confidence
US 7,521,068Dry powder aerosols of nanoparticulate drugs
Formerly held
Term ended
Term ended Nov 11, 2021 · From the USPTO record
Term endedTerm ended Nov 11, 2021From the USPTO record
US 6,267,989Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
Formerly held
Term ended
Term ended Mar 8, 2019 · From the USPTO record
Term endedTerm ended Mar 8, 2019From the USPTO record
US 6,153,225Injectable formulations of nanoparticulate naproxen
Formerly held
Term ended
Term ended Aug 13, 2018 · From the USPTO record
Term endedTerm ended Aug 13, 2018From the USPTO record
US 6,384,519Micro-dynode integrated electron multiplier
Formerly held
Term ended
Term ended Oct 30, 2017 · From the USPTO record
Term endedTerm ended Oct 30, 2017From the USPTO record
US 6,264,922Nebulized aerosols containing nanoparticle dispersions
Formerly held
Term ended
Term ended Oct 9, 2017 · From the USPTO record
Term endedTerm ended Oct 9, 2017From the USPTO record
US 6,045,829Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
Formerly held
Term ended
Term ended Jul 9, 2017 · From the USPTO record
Term endedTerm ended Jul 9, 2017From the USPTO record
US 6,045,677Microporous microchannel plates and method of manufacturing same
Formerly held
Term ended
Term ended Feb 27, 2017 · From the USPTO record
Term endedTerm ended Feb 27, 2017From the USPTO record
US 6,432,381Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract
Formerly held
Lapsed on the fee record
Ended Aug 13, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2014From the USPTO record
US 6,270,806Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
Formerly held
Lapsed on the fee record
Ended Aug 7, 2013 · From the USPTO record
Lapsed on the fee recordEnded Aug 7, 2013From the USPTO record
US 6,221,400Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors
Formerly held
Lapsed on the fee record
Ended Apr 24, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2013From the USPTO record
10 of 87 patents shown.
Pro members see all 87.
Pro members: see all 87 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited